antidepressant | CARLAT PUBLISHING

What You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of Trials

September 27, 2024

In this video, Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, provides a comprehensive review of Gepirone, also known as Exxua, a newly FDA-approved antidepressant for major depressive disorder in adults. Gepirone is unique due to its classification as an azipirone, a class of medications that work as serotonin 5-HT1A receptor agonists.

Viibryd Goes Generic

April 1, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.

Research Update

Therapy in Dementia? Choose CBT

April 1, 2024

Timothy J. Legg, PhD, PsyD, MSN, MPA, MSc

Timothy J. Legg, PhD, PsyD, MSN, MPA, MSc. Dr. Legg has no financial relationships with companies related to this material.

In MCI or dementia, CBT is the only psychological intervention that improves depression, quality of life, and ADLs.

Clinical Update

A Personalized Approach to Antidepressant Augmentation

April 1, 2024

Deepti Anbarasan, MD and David Liebers, MD

Deepti Anbarasan, MD. Associate Professor, Psychiatry and Neurology, New York University, New York, NY.

David Liebers, MD. Psychiatry resident at NYU Langone Department of Psychiatry.

The authors have no financial relationships with companies related to this material.

The best augmentation strategy varies by patient. Learn which features help personalize the plan.

Throwback Benzos

February 15, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants: benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case. (Part 1 of a 2 part series)

Auvelity: 4 Controversies

February 12, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at its side effects, addictive potential, and whether you can just use the generic components.

Auvelity A Fast Acting Antidepressant

February 5, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how it works and the clinical trials, including new data in treatment resistant depression

Expert Q&A

How to Choose an Antidepressant

January 1, 2024

Thomas Schwartz, MD

Thomas Schwartz, MD.

Professor and Chair, Department of Psychiatry and Behavioral Sciences, Alan and Marlene Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY.

Dr. Schwartz has no financial relationships with companies related to this material.

Thomas Schwartz clarifies how to choose an antidepressant and finds a place for underutilized agents like trazodone and levomilnacipran (Fetzima).

Expert Q&A

Management of Depression During Pregnancy and Breastfeeding

October 3, 2023

Karen Horst, MD

Karen Horst, MD.

Assistant Professor, Department of OB/GYN, Baylor College of Medicine; Medical Director, The Women’s Place, Pavilion for Women at Texas Children’s Hospital, Houston, TX.

Dr. Horst has no financial relationships with companies related to this material.

You might worry about prescribing antidepressants during pregnancy, but data on their safety is increasingly reassuring. We provide an in-depth review on how to treat depression in pregnancy and breastfeeding.